N/A N=60 Other

Smartphone Intervention for Overdose and COVID-19

Substance Use Disorders · Overdose · COVID-19

Bottom Line

View on ClinicalTrials.gov: NCT05518461 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2024

Primary outcome: Primary: Content Completion Rate Assessed as Number of Participants Who Completed at Least 6 of the 12 Weeks of the Intervention — 40 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: iThrive WI Intervention (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Wisconsin, Madison
Primary completion: Dec 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Content Completion Rate Assessed as Number of Participants Who Completed at Least 6 of the 12 Weeks of the Intervention	40	—
SECONDARY Number of Days in the Past Month Endorsing Overdose Risk Behaviors	2; 5; 14; 0; 0; 0	—
SECONDARY Change in COVID-19 Vaccination Rates From Baseline	30; 16; 17	—

Summary

This study will examine if the use of a smartphone application called Thrive4Life Connect can help people who use drugs lower their risk of overdose and learn more about COVID-19 vaccines. 60 participants will be enrolled and can expect to be on study for up to 6 months.

Eligibility Criteria

Inclusion Criteria

18 years old or older
Willing to attend in person study encounters at any of the following Vivent Health locations: Milwaukee, Appleton, and Eau Claire
Used opioids to get high in the past 30 days
Injected drugs at least 2 times in the past 7 days
Express interest in reducing their overdose risk

Exclusion Criteria

None in addition to the inclusion criteria

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05518461). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.